CRNX vs TGTX
Crinetics Pharmaceuticals, Inc. · TG Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | CRNX | TGTX |
|---|---|---|
| Price | $83.92 | $49.55 |
| Market Cap | $8.85B | $7.59B |
| P/E | — | 16.96 |
| P/B | 6.91 | 13.01 |
| P/S | 1149.76 | 12.31 |
| ROE | -36.3% | 76.7% |
| Net Margin | -6046.2% | 72.6% |
| Gross Margin | — | — |
| Revenue Growth | 640.7% | 87.3% |
| Dividend Yield | — | — |
| EPS | -$4.41 | $2.92 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.